← Back
$HRMY All transactions

Harmony Biosciences Holdings, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

20,000

Price

$0

Filed

Dec 9

Insider

Name

Kapadia Sandip

Title

CHIEF FINANCIAL OFFICER

CIK

0001677141

Roles

Officer

Transaction Details

Transaction Date

2025-12-05

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

185,000

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $39.63. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The stock option shall vest with respect to 50% of the underlying shares on March 23, 2023 and with respect to the remaining shares, in twenty-four equal monthly installments beginning on April 23, 2023.

Filing Info

Accession No.

0001677141-25-000008

Form Type

4

Issuer CIK

0001802665

Kapadia Sandip's History

Date Ticker Type Value
2026-01-26 HRMY $139K
2026-01-25 HRMY M $0
2026-01-25 HRMY F $94K
2026-01-25 HRMY M $0
2026-01-24 HRMY M $0
2026-01-24 HRMY F $82K
2026-01-24 HRMY M $0
2026-01-22 HRMY A $0
2026-01-22 HRMY A $0
2026-01-15 HRMY $753K

Other Insiders at HRMY (90d)

Insider Bought Sold Last
Ignelzi Troy A. 2026-04-02
Dayno Jeffrey M.
PRESIDENT, CEO
2026-01-25
Kapadia Sandip
CHIEF FINANCIAL OFFICER
$139K 2026-01-26
Serafin Andrew
CHIEF STRATEGY OFFICER
2026-01-25
Anastasiou Peter
CHIEF OPERATING OFFICER
2026-04-02
Budur Kumar
CHIEF MEDICAL OFFICER
2026-01-25
Zaeske Adam H.
CHIEF COMMERCIAL OFFICER
2026-04-07